Earnings call Humana delivered a stronger-than-expected Q2, raising its full-year 2025 EPS guidance from ~$16.25 to ~$17.00. Key drivers included better-than-expected Medicare Advantage (MA) retention ...

Humana ((HUM)) has held its Q3 earnings call. Read on for the main highlights of the call. Humana’s Earnings Call Reflects Positive Performance Amid Challenges Humana’s third quarter earnings call ...

Earnings call Humana increased its full-year 2025 adjusted EPS guidance from ~$16.25 to ~$17, citing better-than-expected Medicare Advantage membership retention and strong CenterWell Pharmacy ...

Humana Inc. reported its second-quarter 2025 earnings, revealing a robust performance driven by its CenterWell Pharmacy and Medicare Advantage memberships. Despite raising its full-year EPS outlook, ...

Refer to the "Footnotes" section included herein for further explanation of disclosures for Adjusted (non-GAAP) financial measures, as well as additional reconciliations. Click to enlarge Detailed ...

Humana Inc. (HUM) reported its third-quarter 2025 earnings, surpassing analyst expectations with an EPS of $3.24 compared to the forecasted $2.83, marking a 14.49% surprise. Revenue reached $32.65 ...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m.

George Renaudin to Retire as Insurance Segment President by Q3 2026 Aaron Martin to Join as President of Medicare Advantage and Insurance Segment President Successor John Barger to Succeed Martin as ...